Emerging resistance mechanisms for 4 types of common anti-MRSA antibiotics in Staphylococcus aureus: A comprehensive review

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Staphylococcus aureus is a major pathogen causing hospital and community infections.
• The rise of methicillin-resistant S. aureus (MRSA) and antibiotic resistance presents a significant therapeutic challenge.
• Existing treatments for MRSA are becoming less effective due to emerging resistance.

Purpose of the Study:

• To review the molecular mechanisms of action for key antibiotics used against S. aureus.
• To summarize known resistance mechanisms against vancomycin, daptomycin, ceftaroline, and linezolid.
• To provide insights for developing novel anti-MRSA drugs based on antibiotic resistance patterns.

Main Methods:

• A systematic literature review of studies published before 2020 was conducted.
• Searches were performed in PubMed for relevant published studies.
• The review focused on antibiotic molecular modes of action and gene mutations associated with resistance.

Main Results:

• The emergence of vancomycin-intermediate S. aureus (VISA) and vancomycin-resistant S. aureus (VRSA) strains is a growing concern.
• Reports on resistance mechanisms for vancomycin, daptomycin, ceftaroline, and linezolid have increased.
• Whole-genome analysis reveals various gene mutants contributing to antibiotic resistance.

Conclusions:

• Understanding the molecular basis of antibiotic resistance in S. aureus is essential.
• Knowledge of resistance mechanisms can guide the development of new therapeutic strategies.
• Further research into novel drug development is needed to combat MRSA effectively.